Omudhome Ogbru, PharmD
Omudhome Ogbru, PharmD
Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.
Medical and Pharmacy Editor:
GENERIC NAME: atazanavir
BRAND NAME: Reyataz
DRUG CLASS AND MECHANISM: Atazanavir is an oral medication that is used for treating infections caused by the human immunodeficiency virus (HIV). It is in a class of drugs called protease inhibitors that also includes ritonavir (Norvir), nelfinavir (Viracept), indinavir (Crixivan) and saquinavir (Invirase, Fortovase). During infection with HIV, the HIV virus multiplies within the body's cells. Viruses are released from the cells and spread throughout the body where they infect other cells. In this manner, HIV infection is perpetuated among new cells that the body produces continually. During the production of the viruses, new proteins must be made. Some of the proteins are structural proteins, that, is, proteins that form the body of the new viruses. Other proteins are enzymes that manufacture DNA and other components for the new viruses. Protease is the enzyme that forms the new structural proteins and enzymes. Atazanavir blocks the activity of protease and results in the formation of new viruses with defective proteins that are unable to infect the body's cells. As a result, the number of viruses in the body (the viral load) decreases. Nevertheless, atazanavir does not prevent the transmission of HIV among individuals, and it does not cure HIV infections or AIDS. Atazanavir was approved by the FDA in June 2003.
GENERIC AVAILABLE: No
PREPARATIONS: Capsules: 100, 150, 200, and 300 mg
STORAGE: Atazanavir should be stored at room temperature, between 15 C to 30 C (59 F to 86 F).
PRESCRIBED FOR: Atazanavir is used in combination with other drugs for the treatment of HIV infections.
DOSING: The starting dose of atazanavir for treatment naive adults is 300 mg atazanavir plus 100 mg ritonavir (Norvir) once daily with food or 400 mg atazanavir once daily with food if unable to tolerate ritonavir.
Ritonavir increases the concentration of atazanavir in the blood. Efavirenz (Sustiva) decreases the concentration of atazanavir in the blood. Therefore, when patients are receiving both atazanavir and efavirenz, 100 mg ritonavir also should be added to 400 mg atazanavir in order to keep the levels of atazanavir in the blood at the desired levels.
Adults who have previously received treatment should not be treated with atazanavir alone. They should receive atazanavir 300 mg plus ritonavir 100 mg once daily or atazanavir 400 mg plus ritonavir 100 mg once daily if also receiving H2-antagonists and tenofovir (Viread) (see drug interactions).
DRUG INTERACTIONS: Atazanavir inhibits the enzymes that eliminate many drugs from the body. Administration of these drugs along with atazanavir may result in increased concentrations of these drugs and cause more side effects. Atazanavir also is eliminated by enzymes in the liver, and drugs that increase the activity of these enzymes may decrease the concentration of atazanavir in the blood and reduce the effect of atazanavir. Conversely, drugs that prevent the elimination of atazanavir may increase the concentration of atazanavir in the blood and cause increased atazanavir-related side effects. Some of the important potential or known interactions are mentioned below. Viewers should consult their health care professional before combining any drugs with atazanavir.
Rifampin (Rifadin), St. John's Wort, tenofovir (Viread), and efavirenz (Sustiva) decrease the blood levels of atazanavir and this can reduce the effect of atazanavir. Dose modifications are necessary when atazanavir is combined with efavirenz or tenofovir. Rifampin and St. John's Wort should not be combined with atazanavir.
Atazanavir decreases the elimination and, therefore, could increase the side effects of triazolam (Halcion), midazolam (Versed), bepridil (Vascor), verapamil (Isoptin) , diltiazem (Cardizem), lovastatin (Mevacor), simvastatin (Zocor), atorvastatin (Lipitor), pimozide (Orap), irinotecan (Camptosar), cyclosporine (Sandimmune), rifabutin (Mycobutin), amiodarone (Cordarone), clarithromycin (Biaxin), alfuzosin (Uroxatral), and ergot drugs (Migranal, Cafergot). Combining atazanavir with lovastatin, simvastatin, pimozide, triazolam, midazolam, irinotecan, ergot drugs, or alfuzosin is contraindicated.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Back to Medications Index